Biogen
BIIB
#909
Rank
HK$165.83 B
Marketcap
HK$1,138
Share price
-0.62%
Change (1 day)
-42.60%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total debt

Total debt on the balance sheet as of September 2024 : HK$51.67 Billion

According to Biogen's latest financial reports the company's total debt is HK$51.67 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Biogen - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31HK$57.31 B10.9%
2022-12-31HK$51.67 B-12.84%
2021-12-31HK$59.28 B-2.3%
2020-12-31HK$60.68 B22.37%
2019-12-31HK$49.59 B6.67%
2018-12-31HK$46.48 B0.2%
2017-12-31HK$46.39 B-8.2%
2016-12-31HK$50.53 B-0.09%
2015-12-31HK$50.58 B1017.84%
2014-12-31HK$4.52 B-2.07%
2013-12-31HK$4.62 B-47.74%
2012-12-31HK$8.84 B6.99%
2011-12-31HK$8.26 B-11.76%
2010-12-31HK$9.36 B9.82%
2009-12-31HK$8.52 B-0.84%
2008-12-31HK$8.60 B-29.42%
2007-12-31HK$12.18 B1520.47%
2006-12-31HK$0.75 B123.27%
2005-12-31HK$0.33 B-94.9%
2004-12-31HK$6.60 B-3.92%
2003-12-31HK$6.87 B1.81%
2002-12-31HK$6.75 B1735.98%
2001-12-31HK$0.36 B-56.85%
2000-12-31HK$0.85 B-2.93%
1999-12-31HK$0.87 B41.14%
1998-12-31HK$0.62 B-12.28%
1997-12-31HK$0.70 B38.41%
1996-12-31HK$0.51 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
HK$469.29 B 808.12%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$180.64 B 249.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$552.28 B 968.71%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$517.61 B 901.62%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$277.78 B 437.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.52 B-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$197.82 B 282.82%๐Ÿ‡ซ๐Ÿ‡ท France
HK$10.78 B-79.13%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$20.77 B-59.79%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$14.91 B-71.13%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands